These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

308 related articles for article (PubMed ID: 30409890)

  • 1. Epidemiology of ALS in Korea using nationwide big data.
    Jun KY; Park J; Oh KW; Kim EM; Bae JS; Kim I; Kim SH
    J Neurol Neurosurg Psychiatry; 2019 Apr; 90(4):395-403. PubMed ID: 30409890
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epidemiology and diagnostic process of amyotrophic lateral sclerosis as distinct from myelopathy: 5-year cohort study of whole-population in South Korea.
    Kim JM; Park JH; Kim HS; Lee JW; Lim HS; Choi WA; Kang SW
    Amyotroph Lateral Scler Frontotemporal Degener; 2018 Nov; 19(7-8):547-554. PubMed ID: 30421999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimating Amyotrophic Lateral Sclerosis and Motor Neuron Disease Prevalence in Portugal Using a Pharmaco-Epidemiological Approach and a Bayesian Multiparameter Evidence Synthesis Model.
    Conde B; Winck JC; Azevedo LF
    Neuroepidemiology; 2019; 53(1-2):73-83. PubMed ID: 31117082
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of amyotrophic lateral sclerosis and effect of riluzole on disease course.
    Cetin H; Rath J; Füzi J; Reichardt B; Fülöp G; Koppi S; Erdler M; Ransmayr G; Weber J; Neumann K; Hagmann M; Löscher WN; Auff E; Zimprich F
    Neuroepidemiology; 2015; 44(1):6-15. PubMed ID: 25571962
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated with assisted ventilation use in amyotrophic lateral sclerosis: a nationwide population-based study in Korea.
    Yoon SY; Kim HK; Kim MJ; Suh JH; Leigh JH
    Sci Rep; 2021 Oct; 11(1):19682. PubMed ID: 34608192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Riluzole and prognostic factors in amyotrophic lateral sclerosis long-term and short-term survival: a population-based study of 1149 cases in Taiwan.
    Lee CT; Chiu YW; Wang KC; Hwang CS; Lin KH; Lee IT; Tsai CP
    J Epidemiol; 2013; 23(1):35-40. PubMed ID: 23117224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Riluzole and other prognostic factors in ALS: a population-based registry study in Italy.
    Mandrioli J; Malerba SA; Beghi E; Fini N; Fasano A; Zucchi E; De Pasqua S; Guidi C; Terlizzi E; Sette E; Ravasio A; Casmiro M; Salvi F; Liguori R; Zinno L; Handouk Y; Rizzi R; Borghi A; Rinaldi R; Medici D; Santangelo M; Granieri E; Mussuto V; Aiello M; Ferro S; Vinceti M;
    J Neurol; 2018 Apr; 265(4):817-827. PubMed ID: 29404735
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Riluzole and amyotrophic lateral sclerosis survival: a population-based study in southern Italy.
    Zoccolella S; Beghi E; Palagano G; Fraddosio A; Guerra V; Samarelli V; Lepore V; Simone IL; Lamberti P; Serlenga L; Logroscino G;
    Eur J Neurol; 2007 Mar; 14(3):262-8. PubMed ID: 17355545
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2003 Sep; 4(3):191-206. PubMed ID: 13129806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiology of Amyotrophic Lateral Sclerosis: A Population-Based Study in Israel.
    Weil C; Zach N; Rishoni S; Shalev V; Chodick G
    Neuroepidemiology; 2016; 47(2):76-81. PubMed ID: 27617889
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of depression in amyotrophic lateral sclerosis: A nationwide cohort study in South Korea.
    Kwon S; Kim B; Han KD; Jung W; Cho EB; Shin DW; Min JH
    J Psychiatr Res; 2024 Oct; 178():414-420. PubMed ID: 39226692
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Identification and outcomes of clinical phenotypes in amyotrophic lateral sclerosis/motor neuron disease: Australian National Motor Neuron Disease observational cohort.
    Talman P; Duong T; Vucic S; Mathers S; Venkatesh S; Henderson R; Rowe D; Schultz D; Edis R; Needham M; Macdonnell R; McCombe P; Birks C; Kiernan M
    BMJ Open; 2016 Sep; 6(9):e012054. PubMed ID: 27694488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiological and clinical features of amyotrophic lateral sclerosis in a Tunisian cohort.
    Kacem I; Sghaier I; Bougatef S; Nasri A; Gargouri A; Ajroud-Driss S; Gouider R
    Amyotroph Lateral Scler Frontotemporal Degener; 2020 Feb; 21(1-2):131-139. PubMed ID: 31858811
    [No Abstract]   [Full Text] [Related]  

  • 14. Prognosis of amyotrophic lateral sclerosis patients after tracheostomy invasive ventilation in Korea.
    Kim JS; Park M; Park S; Chae J; Hong YH; Park KS; Sung JJ; Choi SJ
    Amyotroph Lateral Scler Frontotemporal Degener; 2024 May; 25(3-4):271-281. PubMed ID: 38340017
    [No Abstract]   [Full Text] [Related]  

  • 15. Riluzole for amyotrophic lateral sclerosis (ALS)/motor neuron disease (MND).
    Miller RG; Mitchell JD; Lyon M; Moore DH
    Cochrane Database Syst Rev; 2002; (2):CD001447. PubMed ID: 12076411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical features and prognosis of amyotrophic lateral sclerosis in Africa: the TROPALS study.
    Luna J; Diagana M; Ait Aissa L; Tazir M; Ali Pacha L; Kacem I; Gouider R; Henning F; Basse A; Cisse O; Balogou AAK; Kombate D; Agbetou M; Houinato D; Millogo A; Agba T; Belo M; Penoty M; Raymondeau-Moustafa M; Hamidou B; Couratier P; Preux PM; Marin B;
    J Neurol Neurosurg Psychiatry; 2019 Jan; 90(1):20-29. PubMed ID: 30242088
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence, prevalence, and medical expenditures of classical amyotrophic lateral sclerosis in Taiwan, 1999-2008.
    Tsai CP; Wang KC; Hwang CS; Lee IT; Lee CT
    J Formos Med Assoc; 2015 Jul; 114(7):612-9. PubMed ID: 26154753
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiological Study of Malignant Gliomas in Korea Using Nationwide Dataset from 2007 to 2017.
    Kim SU; Ahn S; Lee JE; Han KD; Park SH; Yang SH
    J Korean Med Sci; 2021 Mar; 36(9):e68. PubMed ID: 33686813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiological and clinical factors impact on the benefit of riluzole in the survival rates of patients with ALS.
    Fávero FM; Voos MC; Castro I; Caromano FA; Oliveira ASB
    Arq Neuropsiquiatr; 2017 Aug; 75(8):515-522. PubMed ID: 28813081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The ALS/MND prevalence in Sweden estimated by riluzole sales statistics.
    Nygren I; Antonova K; Mattsson P; Askmark H
    Acta Neurol Scand; 2005 Mar; 111(3):180-4. PubMed ID: 15691287
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.